← All Genmab A/s filings

Genmab A/s Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
GMAB
Genmab A/s
Form 4: Genmab Completes Merus N.V. Takeover, Shares Delisted
Genmab A/S has finalized its acquisition of Merus N.V., converting all remaining minority shares into cash and delisting the company.
NASDAQ
GMAB
Genmab A/s
Form 4: Genmab Boosts Merus Stake to Over 94% in Tender Offer
Genmab A/S, through its subsidiary, increased its beneficial ownership in Merus N.V. to 72,828,509 common shares following a tender offer and subsequent acquisitions.
NASDAQ
GMAB
Genmab A/s
Form 4: Genmab Boosts Merus Stake to Over 94% in Tender Offer
Genmab A/S, through its subsidiary, has increased its beneficial ownership in Merus N.V. to over 94% following a tender offer and subsequent share acquisitions.
NASDAQ
GMAB
Genmab A/s
Form 4: Genmab Boosts Merus Stake Post-Tender Offer
Genmab A/S, through its subsidiary, acquired additional common shares of Merus N.V. at $97 per share following a tender offer, increasing its beneficial ownership to over 71.7 million shares.